Latest papers

[Triazavirin prophylactic efficacy against influenza virus A (H5N1)].

Expression, purification, and characterization of a recombinant neutral ceramidase from Mycobacterium tuberculosis.

Antagonistic changes in sensitivity to antifungal drugs by mutations of an important ABC transporter gene in a fungal pathogen.

Development of specific inhibitors of CYP707A, a key enzyme in the catabolism of abscisic acid.

In vitro activities of azole antifungal agents against Propionibacterium acnes isolated from patients with acne vulgaris.

Characterization of the multi-drug efflux systems of pathogenic fungi using functional hyperexpression in Saccharomyces cerevisiae.

Use of a yeast-based membrane protein expression technology to overexpress drug resistance efflux pumps.

Photodynamic therapy of bacterial and fungal biofilm infections.

Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.

Inhibitory mechanism of novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferase from Haemophilus influenzae.

The current role of amphotericin B lipid complex in managing systemic fungal infections.

[Cerebral ischaemia: tomorrow's therapeutic tracks].

Assessing the reproductive toxicity of some (con)azole compounds using a structure-activity relationship approach.

Practical catalytic asymmetric synthesis of diaryl-, aryl heteroaryl-, and diheteroarylmethanols.

New generation azole antifungals in clinical investigation.

Structure-based and in silico design of Hsp90 inhibitors.

The optimal wavelength of spectrophotometric broth microdilution antifungal susceptibility test for flucytosine and three azoles.

Metathesis in the synthesis of aromatic compounds.

Serum or bile affects the in vitro azole susceptibilities of Candida spp.

Discrete generations of intracellular hydrogen peroxide and superoxide in antigen-stimulated mast cells: Reciprocal regulation of store-operated Ca2+ channel activity